# Larimar Therapeutics, Inc.: Form 8-K, filed Oct 3, 2023

- Company: [Larimar Therapeutics, Inc.](/companies/lrmr.md) (CIK 1374690)
- Form: 8-K
- Filed: 2023-10-03
- Accepted by EDGAR: Oct 3, 2023, 16:31 ET
- Period: 2023-10-03
- Accession: 0001193125-23-249962
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1374690/000119312523249962/d517569d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1374690/000119312523249962/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1374690/000119312523249962/d517569d8k.htm

Filed Oct 3, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-249962. Last ingested by Listed: Nov 13, 2026, 17:49 ET. No prices; not investment advice.
